BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15026783)

  • 1. Glycerol kinase deficiency: residual activity explained by reduced transcription and enzyme conformation.
    Sjarif DR; Hellerud C; van Amstel JK; Kleijer WJ; Sperl W; Lacombe D; Sass JO; Beemer FA; Duran M; Poll-The BT
    Eur J Hum Genet; 2004 Jun; 12(6):424-32. PubMed ID: 15026783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycerol metabolism and the determination of triglycerides--clinical, biochemical and molecular findings in six subjects.
    Hellerud C; Burlina A; Gabelli C; Ellis JR; Nyholm PG; Lindstedt S
    Clin Chem Lab Med; 2003 Jan; 41(1):46-55. PubMed ID: 12636049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and murine glycerol kinase: influence of exon 18 alternative splicing on function.
    Ohira RH; Dipple KM; Zhang YH; McCabe ER
    Biochem Biophys Res Commun; 2005 May; 331(1):239-46. PubMed ID: 15845384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycerol kinase deficiency: follow-up during 20 years, genetics, biochemistry and prognosis.
    Hellerud C; Wramner N; Erikson A; Johansson A; Samuelson G; Lindstedt S
    Acta Paediatr; 2004 Jul; 93(7):911-21. PubMed ID: 15303806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of a putative human glycerol 3-phosphate permease gene (SLC37A1 or G3PP) on 21q22.3: mutation analysis in two candidate phenotypes, DFNB10 and a glycerol kinase deficiency.
    Bartoloni L; Wattenhofer M; Kudoh J; Berry A; Shibuya K; Kawasaki K; Wang J; Asakawa S; Talior I; Bonne-Tamir B; Rossier C; Michaud J; McCabe ER; Minoshima S; Shimizu N; Scott HS; Antonarakis SE
    Genomics; 2000 Dec; 70(2):190-200. PubMed ID: 11112347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency.
    Sjarif DR; Sinke RJ; Duran M; Beemer FA; Kleijer WJ; Ploos van Amstel JK; Poll-The BT
    J Med Genet; 1998 Aug; 35(8):650-6. PubMed ID: 9719371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic isolated human glycerol kinase deficiency associated with splice-site mutations and nonsense-mediated decay of mutant RNA.
    Zhang YH; Huang BL; Jialal I; Northrup H; McCabe ER; Dipple KM
    Pediatr Res; 2006 Apr; 59(4 Pt 1):590-2. PubMed ID: 16549535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
    Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
    Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations and phenotype in isolated glycerol kinase deficiency.
    Walker AP; Muscatelli F; Stafford AN; Chelly J; Dahl N; Blomquist HK; Delanghe J; Willems PJ; Steinmann B; Monaco AP
    Am J Hum Genet; 1996 Jun; 58(6):1205-11. PubMed ID: 8651297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of glycerol kinase gene in mice: expression analysis in liver shows alterations in network partners related to glycerol kinase activity.
    MacLennan NK; Rahib L; Shin C; Fang Z; Horvath S; Dean J; Liao JC; McCabe ER; Dipple KM
    Hum Mol Genet; 2006 Feb; 15(3):405-15. PubMed ID: 16368706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
    Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
    Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
    Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Null mutations and lethal congenital form of glycogen storage disease type IV.
    Assereto S; van Diggelen OP; Diogo L; Morava E; Cassandrini D; Carreira I; de Boode WP; Dilling J; Garcia P; Henriques M; Rebelo O; ter Laak H; Minetti C; Bruno C
    Biochem Biophys Res Commun; 2007 Sep; 361(2):445-50. PubMed ID: 17662246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of highly thermostable glycerol kinase from a hyperthermophilic archaeon in a dimeric form.
    Koga Y; Katsumi R; You DJ; Matsumura H; Takano K; Kanaya S
    FEBS J; 2008 May; 275(10):2632-43. PubMed ID: 18422647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutation (Gly280Ala) in the ATP-binding domain of glycerol kinase causes severe hyperglycerolemia.
    Wibmer T; Otto J; Parhofer KG; Otto C
    Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):396-403. PubMed ID: 16025401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycerol kinase deficiency: evidence for complexity in a single gene disorder.
    Dipple KM; Zhang YH; Huang BL; McCabe LL; Dallongeville J; Inokuchi T; Kimura M; Marx HJ; Roederer GO; Shih V; Yamaguchi S; Yoshida I; McCabe ER
    Hum Genet; 2001 Jul; 109(1):55-62. PubMed ID: 11479736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.